vs
CSW INDUSTRIALS, INC.（CSW）とNutex Health, Inc.（NUTX）の財務データ比較。上の社名をクリックして会社を切り替えられます
CSW INDUSTRIALS, INC.の直近四半期売上が大きい（$233.0M vs $151.7M、Nutex Health, Inc.の約1.5倍）。Nutex Health, Inc.の純利益率が高く（7.8% vs 4.4%、差は3.4%）。CSW INDUSTRIALS, INC.の前年同期比売上増加率が高い（20.3% vs -41.1%）。Nutex Health, Inc.の直近四半期フリーキャッシュフローが多い（$69.0M vs $22.7M）。過去8四半期でNutex Health, Inc.の売上複合成長率が高い（50.0% vs 5.1%）
Nutex Healthはアメリカ合衆国テキサス州ヒューストンに本社を置く営利目的の医療企業で、各種医療機関の運営を主な事業としています。米国本土で医療関連事業を展開し、地域に向けて関連する医療サービスと施設運営を提供しています。
CSW vs NUTX — 直接比較
売上が大きい
CSW
1.5倍大きい
$151.7M
売上成長率が高い
CSW
+61.4%の差
-41.1%
純利益率が高い
NUTX
純利益率が3.4%高い
4.4%
フリーキャッシュフローが多い
NUTX
FCF $46.3M多い
$22.7M
2年売上CAGRが高い
NUTX
2年複合成長率
5.1%
損益計算書 — Q3 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $233.0M | $151.7M |
| 純利益 | $10.3M | $11.8M |
| 粗利率 | 39.7% | 30.4% |
| 営業利益率 | 7.4% | 20.4% |
| 純利益率 | 4.4% | 7.8% |
| 売上前年比 | 20.3% | -41.1% |
| 純利益前年比 | -61.9% | -80.8% |
| EPS（希薄化後） | $0.62 | $2.34 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
売上CSWNUTX
| Q4 25 | $233.0M | $151.7M | ||
| Q3 25 | $277.0M | $267.8M | ||
| Q2 25 | $263.6M | $244.0M | ||
| Q1 25 | $230.5M | $211.8M | ||
| Q4 24 | $193.6M | $257.6M | ||
| Q3 24 | $227.9M | $78.8M | ||
| Q2 24 | $226.2M | $76.1M | ||
| Q1 24 | $210.9M | $67.5M |
純利益CSWNUTX
| Q4 25 | $10.3M | $11.8M | ||
| Q3 25 | $40.7M | $55.4M | ||
| Q2 25 | $40.9M | $-17.7M | ||
| Q1 25 | $35.1M | $21.2M | ||
| Q4 24 | $26.9M | $61.6M | ||
| Q3 24 | $36.1M | $-8.8M | ||
| Q2 24 | $38.6M | $-364.0K | ||
| Q1 24 | $31.8M | $-364.0K |
粗利率CSWNUTX
| Q4 25 | 39.7% | 30.4% | ||
| Q3 25 | 43.0% | 57.8% | ||
| Q2 25 | 43.8% | 51.2% | ||
| Q1 25 | 44.2% | 55.9% | ||
| Q4 24 | 41.4% | 55.0% | ||
| Q3 24 | 45.6% | 27.8% | ||
| Q2 24 | 47.5% | 29.7% | ||
| Q1 24 | 44.4% | 15.1% |
営業利益率CSWNUTX
| Q4 25 | 7.4% | 20.4% | ||
| Q3 25 | 20.5% | 48.7% | ||
| Q2 25 | 20.8% | 13.8% | ||
| Q1 25 | 19.5% | 38.1% | ||
| Q4 24 | 15.3% | 44.4% | ||
| Q3 24 | 22.6% | 12.3% | ||
| Q2 24 | 24.3% | 7.0% | ||
| Q1 24 | 21.0% | 2.1% |
純利益率CSWNUTX
| Q4 25 | 4.4% | 7.8% | ||
| Q3 25 | 14.7% | 20.7% | ||
| Q2 25 | 15.5% | -7.3% | ||
| Q1 25 | 15.2% | 10.0% | ||
| Q4 24 | 13.9% | 23.9% | ||
| Q3 24 | 15.8% | -11.2% | ||
| Q2 24 | 17.1% | -0.5% | ||
| Q1 24 | 15.1% | -0.5% |
EPS（希薄化後）CSWNUTX
| Q4 25 | $0.62 | $2.34 | ||
| Q3 25 | $2.41 | $7.76 | ||
| Q2 25 | $2.43 | $-2.95 | ||
| Q1 25 | $2.05 | $3.33 | ||
| Q4 24 | $1.60 | $11.56 | ||
| Q3 24 | $2.26 | $-1.72 | ||
| Q2 24 | $2.47 | $-0.07 | ||
| Q1 24 | $2.03 | $-0.08 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $40.2M | $185.6M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $1.1B | $329.4M |
| 総資産 | $2.3B | $918.5M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
現金・短期投資CSWNUTX
| Q4 25 | $40.2M | $185.6M | ||
| Q3 25 | $31.5M | $166.0M | ||
| Q2 25 | $38.0M | $96.7M | ||
| Q1 25 | $225.8M | $84.7M | ||
| Q4 24 | $213.8M | $40.6M | ||
| Q3 24 | $273.2M | $46.9M | ||
| Q2 24 | $18.9M | $40.8M | ||
| Q1 24 | $22.2M | $30.0M |
総負債CSWNUTX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
株主資本CSWNUTX
| Q4 25 | $1.1B | $329.4M | ||
| Q3 25 | $1.1B | $317.2M | ||
| Q2 25 | $1.1B | $235.3M | ||
| Q1 25 | $1.1B | $176.9M | ||
| Q4 24 | $1.0B | $132.4M | ||
| Q3 24 | $1.0B | $60.4M | ||
| Q2 24 | $650.2M | $62.7M | ||
| Q1 24 | $615.7M | $63.0M |
総資産CSWNUTX
| Q4 25 | $2.3B | $918.5M | ||
| Q3 25 | $1.5B | $964.5M | ||
| Q2 25 | $1.5B | $841.0M | ||
| Q1 25 | $1.4B | $761.9M | ||
| Q4 24 | $1.4B | $655.3M | ||
| Q3 24 | $1.4B | $438.5M | ||
| Q2 24 | $1.1B | $422.4M | ||
| Q1 24 | $1.0B | $404.3M |
負債/資本比率CSWNUTX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.9M | $70.4M |
| フリーキャッシュフロー営業CF - 設備投資 | $22.7M | $69.0M |
| FCFマージンFCF / 売上 | 9.8% | 45.5% |
| 設備投資強度設備投資 / 売上 | 2.6% | 0.9% |
| キャッシュ転換率営業CF / 純利益 | 2.81× | 5.95× |
| 直近12ヶ月FCF直近4四半期 | $162.0M | $245.6M |
8四半期トレンド — 暦四半期で整列
営業キャッシュフローCSWNUTX
| Q4 25 | $28.9M | $70.4M | ||
| Q3 25 | $61.8M | $99.5M | ||
| Q2 25 | $60.6M | $27.3M | ||
| Q1 25 | $27.3M | $51.0M | ||
| Q4 24 | $11.6M | $54.0K | ||
| Q3 24 | $66.8M | $6.8M | ||
| Q2 24 | $62.7M | $13.3M | ||
| Q1 24 | $22.4M | $3.1M |
フリーキャッシュフローCSWNUTX
| Q4 25 | $22.7M | $69.0M | ||
| Q3 25 | $58.7M | $99.2M | ||
| Q2 25 | $57.7M | $26.5M | ||
| Q1 25 | $22.8M | $50.9M | ||
| Q4 24 | $8.5M | $-341.0K | ||
| Q3 24 | $61.3M | $6.2M | ||
| Q2 24 | $59.6M | $12.7M | ||
| Q1 24 | $17.5M | $2.3M |
FCFマージンCSWNUTX
| Q4 25 | 9.8% | 45.5% | ||
| Q3 25 | 21.2% | 37.0% | ||
| Q2 25 | 21.9% | 10.9% | ||
| Q1 25 | 9.9% | 24.0% | ||
| Q4 24 | 4.4% | -0.1% | ||
| Q3 24 | 26.9% | 7.8% | ||
| Q2 24 | 26.3% | 16.7% | ||
| Q1 24 | 8.3% | 3.4% |
設備投資強度CSWNUTX
| Q4 25 | 2.6% | 0.9% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | 1.1% | 0.3% | ||
| Q1 25 | 2.0% | 0.0% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.4% | 0.8% | ||
| Q2 24 | 1.4% | 0.7% | ||
| Q1 24 | 2.3% | 1.1% |
キャッシュ転換率CSWNUTX
| Q4 25 | 2.81× | 5.95× | ||
| Q3 25 | 1.52× | 1.80× | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 0.78× | 2.40× | ||
| Q4 24 | 0.43× | 0.00× | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
